MedPath

Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)

Phase 3
Completed
Conditions
Benign Prostatic Hypertrophy
Interventions
Registration Number
NCT00670306
Lead Sponsor
AEterna Zentaris
Brief Summary

Benign Prostatic Hyperplasia (BPH) is the most common hyperplastic disease occuring in human males over the age of 50 which increases in prevalence with age and 40% of males reported moderate or severe urinary symptoms of prostatism by the age of 50 to 80. The purpose of this study is to collect safety and efficacy data for this dosage regimen of cetrorelix pamoate.

For this study, study medication (Cetrorelix pamoate) is administered by injection in the buttocks (Intramuscular).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
528
Inclusion Criteria
  • Benign Prostatic Hyperplasia, based on medical history
  • Voiding symptoms
  • Uroflow (max) 5-15mL/sec
Exclusion Criteria
  • Urgent need for prostate surgery
  • History of allergic reaction to peptide
  • Major organ dysfunction
  • Prior surgical treatment of the prostate or bladder
  • Current or recent treatment with sexual hormone drugs or 5 α reductase inhibitors or botulinum toxin type a (Botox) within the last 6 months prior to trial medication at Week 0 or with α blockers or saw palmetto within the last 6 weeks prior to trial medication at Week 0
  • Urologic disorders including neurogenic bladder dysfunction due to diabetes mellitus or documented neurologic disorder, urethral stricture disease or history of pelvic radiation therapy
  • History of acute obstructive, infectious, or neurological disorders of the genitourinary tract within the last 3 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Cetrorelix 78 mgCetrorelix PamoateDrug: Cetrorelix 52 mg week 0, and 26 mg week 2, intra muscular-2 doses in 2 weeks and follow up to week 26.
Primary Outcome Measures
NameTimeMethod
IPSS Change From BaselineBaseline and Week 26

International Prostate Symptom Score (IPSS) Patient Questionnaire assessing 7 items (incomplete voiding, frequency, intermittency, urgency, weak stream, hesitancy, nocturia) on a scale from 0 (best) to 5 (worst); total range: 0 - 35 points; absolute change from baseline to Week 26

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (69)

Dr. Jonathan Giddens

🇨🇦

Brampton, Ontario, Canada

South Florida Medical Research

🇺🇸

Aventura, Florida, United States

Five Valleys Urology

🇺🇸

Missoula, Montana, United States

Delaware Valley Urology, LLC-Voorhees

🇺🇸

Voorhees, New Jersey, United States

Can-Med Clinical Research Inc.

🇨🇦

Victoria, British Columbia, Canada

South Orange County Medical Research Center

🇺🇸

Laguna Hills, California, United States

Regional Urology, LLC

🇺🇸

Shreveport, Louisiana, United States

Upstate Urology

🇺🇸

Albany, New York, United States

Advanced Urology

🇺🇸

Jackson Heights, New York, United States

Urology of Virginia

🇺🇸

Virginia Beach, Virginia, United States

North Idaho Urology

🇺🇸

Coeur d'Alene, Idaho, United States

Omega Medical Research

🇺🇸

Warwick, Rhode Island, United States

University Urology Associates

🇺🇸

New-York, New York, United States

Medical Affiliated Research Center, Inc.

🇺🇸

Huntsville, Alabama, United States

Specialists in Urology

🇺🇸

Naples, Florida, United States

Welborn Clinic

🇺🇸

Newburgh, Indiana, United States

Michigan Institute of Urology

🇺🇸

Troy, Michigan, United States

Northeast Urology Research

🇺🇸

Concord, North Carolina, United States

Urologic Consultants of SEPA

🇺🇸

Bala Cynwyd, Pennsylvania, United States

Northeast Indiana Research, LLC

🇺🇸

Fort Wayne, Indiana, United States

Four Rivers Clinical Research

🇺🇸

Paducah, Kentucky, United States

Myron I. Murdock M.D. LLC

🇺🇸

Greenbelt, Maryland, United States

California Professionnal Research

🇺🇸

Newport Beach, California, United States

Florida Urology Specialists

🇺🇸

Sarasota, Florida, United States

Winter Park Urology

🇺🇸

Orlando, Florida, United States

The Iowa Clinic

🇺🇸

Des Moines, Iowa, United States

Urological Associates of Lancaster

🇺🇸

Lancaster, Pennsylvania, United States

Delaware Valley Urology, LLC

🇺🇸

Westampton, New Jersey, United States

The Male / FemaleHealth and Research Center

🇨🇦

Barrie, Ontario, Canada

Brantford Urology Research

🇨🇦

Brantford, Ontario, Canada

Mor Urology, Inc.

🇨🇦

New Market, Ontario, Canada

Mount Vernon Clinical Research, LLC

🇺🇸

Sandy Springs, Georgia, United States

Lawrenceville Urology, P.A. dba AdvanceMed Research

🇺🇸

Lawrenceville, New Jersey, United States

Medical & Clinical Research Associates

🇺🇸

Bay Shore, New York, United States

The Fe/Male Health Centres

🇨🇦

Oakville, Ontario, Canada

Washington University School of Medicine

🇺🇸

St-Louis, Missouri, United States

New York University School of Medicine

🇺🇸

New York, New York, United States

Capital Region Urologic Surgeons

🇺🇸

Albany, New York, United States

Urology Associates-Rochester

🇺🇸

Rochester, New York, United States

Parkhurst Research Oganization Inc.

🇺🇸

Bethany, Oklahoma, United States

Urologic Associates, Urologic Medical Research

🇨🇦

Kitchener, Ontario, Canada

Dr. Bernard Goldfarb, MD

🇨🇦

North Bay, Ontario, Canada

Seattle Urology Research

🇺🇸

Seattle, Washington, United States

San Diego Uro Research

🇺🇸

San Diego, California, United States

Medical Center for Clinical Research

🇺🇸

San Diego, California, United States

Salt Lake Research, PLLC

🇺🇸

Salt Lake City, Utah, United States

Genitourinary Surgical Consultants

🇺🇸

Denver, Colorado, United States

The Urology Group

🇺🇸

Cincinnati, Ohio, United States

Sheldon J. Freedman, MD, LTD

🇺🇸

Las Vegas, Nevada, United States

Dr. John Mahoney

🇨🇦

Ottawa,, Ontario, Canada

Allan Abramovitch, MD

🇨🇦

Scarborough, Ontario, Canada

The Male Health Center

🇨🇦

Toronto, Ontario, Canada

Quality Clinical Research, Inc.

🇺🇸

Omaha, Nebraska, United States

Meridian Clinical Research LLC

🇺🇸

Omaha, Nebraska, United States

West Coast Clinical Research

🇺🇸

Tarzana, California, United States

Urology Centers of Alabama

🇺🇸

Homewood, Alabama, United States

Urological Associates of Bridgeport

🇺🇸

Trumbull, Connecticut, United States

Northern California Research

🇺🇸

Sacramento, California, United States

Connecticut Clincal Research Center, LLC

🇺🇸

Middlebury, Connecticut, United States

Tampa Bay Medical Research

🇺🇸

Clearwater, Florida, United States

Chesapeake Urology Research Associates

🇺🇸

Bel Air, Maryland, United States

University Urologists

🇺🇸

Lake Worth, Florida, United States

Urological Surgeons of Long Island, Clinical Research Division

🇺🇸

Garden City, New York, United States

Carolina Urologic Research Center

🇺🇸

Myrtle Beach, South Carolina, United States

Piedmont Medical Group

🇺🇸

Winston-Salem, North Carolina, United States

Guelph Urology Associates

🇨🇦

Guelph, Ontario, Canada

Anthony Skehan Medicine Professional Corp.

🇨🇦

Thunder Bay,, Ontario, Canada

University of Texas Southwestern Medical Center, Department of Urology

🇺🇸

Dallas, Texas, United States

Matrix Research

🇺🇸

Greer, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath